Empirico

Empress Therapeutics

Empress Therapeutics develops oral small-molecule medicines for diverse diseases by using a platform to identify chemical compounds produced by the human body.

Empress

This company develops small molecule medicines and a drug discovery platform for pharmaceutical firms to treat various human diseases.

CaMaRa

This company identifies genetic targets to develop novel treatments for patients with cardiometabolic and renal diseases.

Adrestia

This company develops precision medicines for rare and common genetic diseases by using a molecular biology platform to identify and rescue cellular imbalances.

Healthcare insights platform

This company provides a data analytics platform that integrates genetic information and clinical research to assist pharmaceutical firms in developing precision medicine and treatments.

Strategic Partners

This company develops drug candidates for serious genetic disorders to serve patients with rare diseases.

Fauna Bio

This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners by analysing genetic data from disease-resistant animal species.

Code Bio

This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.